<DOC>
	<DOCNO>NCT00413608</DOCNO>
	<brief_summary>To test pharmacodynamic response clopidogrel 150mg daily 7 day healthy subject carrier mutate allele ( *2 ) associate CYP2C19 deficiency non responder usual regimen 75 mg daily</brief_summary>
	<brief_title>Influence CYP2C19 Genetic Variants Clopidogrel Healthy Subjects</brief_title>
	<detailed_description>Thirty individual genotyped specific variant 2C19 cytochrome P2Y12 platelet ADP receptor receive one week daily dose 75 mg clopidogrel . Depending pharmacodynamic response dose clopidogrel , subject affiliate two group , `` good responder '' `` bad responder '' . After wash-out period , `` bad responder '' receive double dose clopidogrel , `` good responder '' receive 75 mg clopidogrel , associate CYP2C19 inhibitor . Such study allow evaluate impact raise daily dose clopidogrel patient defect variant 2C19 potential interaction clopidogrel drug .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Healthy volunteer , age 18 35 , non smoker , caucasian origin Compatible 2C19 P2Y12 genotype Weight 60 kg 100 kg , normal BMI Standard laboratory investigation normal Negative test HIV infection B C hepatitis Basal platelet agregation test normal EKG , blood pressure cardiac frequency normal range Ability understand , follow sign protocol Evolutive medical affection , even treat Medical history allergic response medication , peptic ulcer , know hemorrhagic disorder Laboratory test normal range Subjects practice violent sport Unability understand follow protocol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Human</keyword>
	<keyword>Adults</keyword>
	<keyword>Male</keyword>
	<keyword>Alleles</keyword>
	<keyword>Genotype</keyword>
	<keyword>Platelet Aggregation/drug effect</keyword>
	<keyword>Platelet Aggregation Inhibitors/*pharmacology</keyword>
	<keyword>Platelet Function Tests</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>*Polymorphism , Genetic</keyword>
	<keyword>Ticlopidine/*analogs &amp; derivatives/pharmacology</keyword>
	<keyword>Healthy subject</keyword>
</DOC>